Temperature Dependent Changes in I-gel Masks

Sponsor
Johann Wolfgang Goethe University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03976726
Collaborator
(none)
15
1
2
7.6

Study Details

Study Description

Brief Summary

The i-gel® mask is a second generation, single use supraglottic airway device which does not have an inflatable cuff. The cuff consists of a thermoplastic elastomer and its mechanism of sealing still remains unclear. Various theories such as temperature-dependent changes in hardness and volume expansion as well as fluid absorption have been discussed.

Condition or Disease Intervention/Treatment Phase
  • Device: Comparison of physcial parameters

Detailed Description

The i-gel® mask (Intersurgical, Workingham, UK), is a second generation, single use supraglottic airway device. In contrast to other devices its' cuff consists of a thermoplastic elastomer (styrene-ethylene-butadine-styrene) instead of an inflatable cuff.

Previous studies have shown, that over time the sealing improved compared to the moment of insertion. The sealing process may be based on various mechanisms. It is assumed, that the warming from room to body temperature leads to an improved adaptation to the patient-specific anatomy due to a softening of the elastomer. By definition, an elastomer is softened by the effect of temperature and become harder when reaching the glass transition temperature.

In this context, Dingley et al. described a change in the degree of hardness as a function of temperature. Prewarmed i-gel® masks (42°C, 30min.) seem to have smaller leak volumes compared to masks stored at room temperature postinsertion in paralyzed patients, but was not reproducible in non-paralyzed patients. Looking at the sealing pressure Chauhan et al. reported that i-gel® masks required a lower pressure compared to masks with an inflatable cuff.

At this point it is not yet clear, whether the thermoplastic cuff material only expands due to an increase in temperature. Liquid absorption and a consecutive expansion is also theoretically conceivable.

Therefore, the aim of the present study is to examine the i-gel® mask within the scope of a benchtop study for temperature-dependent volume expansion and liquid absorption.

Study Design

Study Type:
Observational
Actual Enrollment :
15 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Influence of Temperature on Volume, Weight and Density Changes of I-gel® Masks
Actual Study Start Date :
Apr 1, 2019
Actual Primary Completion Date :
May 10, 2019
Actual Study Completion Date :
May 31, 2019

Arms and Interventions

Arm Intervention/Treatment
i-gel size #3

Results of benchtop investigations are compared to in patient-used masks. Increasement of weight, volume expansion and decrease of density are measured.

Device: Comparison of physcial parameters
Increasement of weight, volume expansion and decrease of density are measured.

i-gel size #4

Results of benchtop investigations are compared to in patient-used masks. Increasement of weight, volume expansion and decrease of density are measured.

Device: Comparison of physcial parameters
Increasement of weight, volume expansion and decrease of density are measured.

i-gel size #5

Results of benchtop investigations are compared to in patient-used masks. Increasement of weight, volume expansion and decrease of density are measured.

Device: Comparison of physcial parameters
Increasement of weight, volume expansion and decrease of density are measured.

Outcome Measures

Primary Outcome Measures

  1. Weight [Two consecutive measurements within 15 minutes once the mask temperature has cooled from body temperature to room temperature.]

    Changes of masks weight.

  2. Volume [Two consecutive measurements within 15 minutes once the mask temperature has cooled from body temperature to room temperature.]

    Changes of masks volume.

  3. Density [Two consecutive measurements within 15 minutes once the mask temperature has cooled from body temperature to room temperature.]

    Changes of masks density.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Elective surgery
Exclusion Criteria:
  • Contraindications for the use of i-gel masks.

  • Emergency operation

  • non fasted patient

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Frankfurt Frankfurt am Main Hessen Germany 60590

Sponsors and Collaborators

  • Johann Wolfgang Goethe University Hospital

Investigators

  • Principal Investigator: Florian J Raimann, Dr., University Hospital Frankfurt

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. med. Florian Raimann, Principal Investigator, Johann Wolfgang Goethe University Hospital
ClinicalTrials.gov Identifier:
NCT03976726
Other Study ID Numbers:
  • 05/19
First Posted:
Jun 6, 2019
Last Update Posted:
Jun 6, 2019
Last Verified:
Jun 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. med. Florian Raimann, Principal Investigator, Johann Wolfgang Goethe University Hospital

Study Results

No Results Posted as of Jun 6, 2019